Insider Transactions in Q2 2025 at Replimune Group, Inc. (REPL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2025
|
Sushil Patel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
166,667
+31.13%
|
-
|
|
Apr 01
2025
|
Andrew Schwendenman Chief Accounting Officer |
SELL
Grant, award, or other acquisition
|
Direct |
33,333
-31.77%
|
-
|
|
Apr 01
2025
|
Christopher Sarchi Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+25.42%
|
-
|
|
Apr 01
2025
|
Emily Luisa Hill Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+23.55%
|
-
|
|
Apr 01
2025
|
Konstantinos Xynos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+22.51%
|
-
|